To examine the role of CS in cancer-specific CD8+ T-cell responses, we used E.G7-OVA (29), which was developed by introducing the gene encoding full-length OVA into a mouse T-cell lymphoma cell line, EL4. This evidence concerns the gene CD8A and cancer.